Status:
COMPLETED
Investigation of Interactions Between Faldaprevir, Itraconazole, Atorvastatin and Rosuvastatin
Lead Sponsor:
Boehringer Ingelheim
Conditions:
Healthy
Eligibility:
All Genders
18-50 years
Phase:
PHASE1
Brief Summary
To investigate the effect of steady-state itraconazole on the pharmacokinetics of steady-state of faldaprevir and the effect of steady-state of faldaprevir on the single-dose pharmacokinetics of atorv...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- 1\. Healthy male and female subjects
- Exclusion criteria:
- 1\. Any relevant deviation from healthy conditions
Exclusion
Key Trial Info
Start Date :
February 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2013
Estimated Enrollment :
51 Patients enrolled
Trial Details
Trial ID
NCT01795937
Start Date
February 1 2013
End Date
March 1 2013
Last Update
August 3 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
1220.61.1 Boehringer Ingelheim Investigational Site
Ingelheim, Germany